المؤلفون: Albiges, Laurence¹ (AUTHOR) laurence.albiges@gustaveroussy.fr, Gurney, Howard² (AUTHOR), Atduev, Vagif³ (AUTHOR), Suarez, Cristina⁴ (AUTHOR), Climent, Miguel A⁵ (AUTHOR), Pook, David⁶ (AUTHOR), Tomczak, Piotr⁷ (AUTHOR), Barthelemy, Philippe⁸ (AUTHOR), Lee, Jae Lyun⁹ (AUTHOR), Stus, Viktor¹⁰ (AUTHOR), Ferguson, Thomas¹¹ (AUTHOR), Wiechno, Pawel¹² (AUTHOR), Gokmen, Erhan¹³ (AUTHOR), Lacombe, Louis¹⁴ (AUTHOR), Gedye, Craig¹⁵ (AUTHOR), Perini, Rodolfo F¹⁶ (AUTHOR), Sharma, Manish¹⁶ (AUTHOR), Peng, Xiang¹⁶ (AUTHOR), Lee, Chung-Han^1,17 (AUTHOR)

المصدر: Lancet Oncology. Aug2023, Vol. 24 Issue 8, p881-891. 11p.

مصطلحات موضوعية: *RENAL cell carcinoma, *KARNOFSKY Performance Status, *STROKE, *ADVERSE health care events, *PEMBROLIZUMAB, *HEART failure

المؤلفون: Bedke, Jens¹ (AUTHOR) jens.bedke@med.uni-tuebingen.de, Rini, Brian I.² (AUTHOR), Plimack, Elizabeth R.³ (AUTHOR), Stus, Viktor⁴ (AUTHOR), Gafanov, Rustem⁵ (AUTHOR), Waddell, Tom⁶ (AUTHOR), Nosov, Dimitry⁷ (AUTHOR), Pouliot, Frederic⁸ (AUTHOR), Soulières, Denis⁹ (AUTHOR), Melichar, Bohuslav¹⁰ (AUTHOR), Vynnychenko, Ihor¹¹ (AUTHOR), Azevedo, Sergio J.¹² (AUTHOR), Borchiellini, Delphine¹³ (AUTHOR), McDermott, Raymond S.¹⁴ (AUTHOR), Tamada, Satoshi¹⁵ (AUTHOR), Nguyen, Allison Martin¹⁶ (AUTHOR), Wan, Shuyan¹⁶ (AUTHOR), Perini, Rodolfo F.¹⁶ (AUTHOR), Rhoda Molife, L.¹⁷ (AUTHOR), Atkins, Michael B.¹⁸ (AUTHOR)

المصدر: European Urology. Oct2022, Vol. 82 Issue 4, p427-439. 13p.

مصطلحات موضوعية: *RENAL cell carcinoma, *SUNITINIB, *QUALITY of life, *PEMBROLIZUMAB, *RENAL cancer

المؤلفون: Motzer, Robert¹ (AUTHOR) motzerr@mskcc.org, Porta, Camillo^2,3 (AUTHOR), Alekseev, Boris⁴ (AUTHOR), Rha, Sun Young⁵ (AUTHOR), Choueiri, Toni K⁶ (AUTHOR), Mendez-Vidal, Maria Jose⁷ (AUTHOR), Hong, Sung-Hoo⁸ (AUTHOR), Kapoor, Anil⁹ (AUTHOR), Goh, Jeffrey C¹⁰ (AUTHOR), Eto, Masatoshi¹¹ (AUTHOR), Bennett, Lee¹² (AUTHOR), Wang, Jinyi¹² (AUTHOR), Pan, Jie Janice¹³ (AUTHOR), Saretsky, Todd L¹⁴ (AUTHOR), Perini, Rodolfo F¹⁴ (AUTHOR), He, Cixin Steven¹³ (AUTHOR), Mody, Kalgi¹³ (AUTHOR), Cella, David¹⁵ (AUTHOR)

المصدر: Lancet Oncology. Jun2022, Vol. 23 Issue 6, p768-780. 13p.

مصطلحات موضوعية: *RENAL cell carcinoma, *QUINOLINE, *RESEARCH, *UREA, *CLINICAL trials, *RESEARCH methodology, *ANTINEOPLASTIC agents, *MONOCLONAL antibodies, *EVALUATION research, *COMPARATIVE studies, *RANDOMIZED controlled trials, *QUALITY of life, *RESEARCH funding

المؤلفون: Luke, Jason J.¹ (AUTHOR) lukejj@upmc.edu, Long, Georgina V.² (AUTHOR), Robert, Caroline³ (AUTHOR), Carlino, Matteo S.⁴ (AUTHOR), Choueiri, Toni K.⁵ (AUTHOR), Haas, Naomi B.⁶ (AUTHOR), O'Brien, Mary⁷ (AUTHOR), Paz-Ares, Luis⁸ (AUTHOR), Peters, Solange⁹ (AUTHOR), Powles, Thomas¹⁰ (AUTHOR), Leiby, Melanie A.¹¹ (AUTHOR), Lin, Jianxin¹¹ (AUTHOR), Zhao, Yujie¹¹ (AUTHOR), Krepler, Clemens¹¹ (AUTHOR), Perini, Rodolfo F.¹¹ (AUTHOR), Catherine Pietanza, M.¹¹ (AUTHOR), Samkari, Ayman¹¹ (AUTHOR), Gruber, Todd¹¹ (AUTHOR), Ibrahim, Nageatte¹¹ (AUTHOR), Eggermont, Alexander M.M.^1,12 (AUTHOR)

المصدر: European Journal of Cancer. Aug2024, Vol. 207, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *THERAPEUTIC use of monoclonal antibodies, *ADRENOCORTICAL hormones, *MELANOMA, *PATIENT safety, *DRUG side effects, *DESCRIPTIVE statistics, *TREATMENT duration, *MONOCLONAL antibodies, *RENAL cell carcinoma, *LUNG cancer, *DISEASE relapse, *DISEASE risk factors

المؤلفون: Jonasch, Eric¹ (AUTHOR) ejonasch@mdanderson.org, Bauer, Todd M.² (AUTHOR), Papadopoulos, Kyriakos P.³ (AUTHOR), Plimack, Elizabeth R.⁴ (AUTHOR), Merchan, Jaime R.⁵ (AUTHOR), McDermott, David F.⁶ (AUTHOR), Dror Michaelson, M.⁷ (AUTHOR), Appleman, Leonard J.⁸ (AUTHOR), Roy, Ananya⁹ (AUTHOR), Perini, Rodolfo F.⁹ (AUTHOR), Liu, Yanfang⁹ (AUTHOR), Choueiri, Toni K.^1,10 (AUTHOR) toni_choueiri@dfci.harvard.edu

المصدر: European Journal of Cancer. Jan2024, Vol. 196, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *RENAL cell carcinoma, *DRUG efficacy, *DISEASE progression, *CLINICAL trials, *DRUG dosage, *ORAL drug administration, *ANTINEOPLASTIC agents, *TREATMENT effectiveness, *DESCRIPTIVE statistics, *ANEMIA, *LONGITUDINAL method, *DRUG toxicity, *HYPOXEMIA, *DISEASE risk factors, *EVALUATION

المؤلفون: Shah, Neil J.¹ (AUTHOR) ShahN6@mskcc.org, Sura, Sneha D.² (AUTHOR), Shinde, Reshma³ (AUTHOR), Shi, Junxin² (AUTHOR), Singhal, Puneet³ (AUTHOR), Perini, Rodolfo F.³ (AUTHOR), Motzer, Robert J.¹ (AUTHOR)

المصدر: Urologic Oncology. Nov2023, Vol. 41 Issue 11, p459.e1-459.e8. 1p.

مصطلحات موضوعية: *RENAL cell carcinoma, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *DISEASE risk factors, *ELECTRONIC health records

المؤلفون: Balar, Arjun V¹ arjun.balar@nyumc.org, Castellano, Daniel², O'Donnell, Peter H³, Grivas, Petros⁴, Vuky, Jacqueline⁵, Powles, Thomas⁶, Plimack, Elizabeth R⁷, Hahn, Noah M⁸, de Wit, Ronald⁹, Pang, Lei¹⁰, Savage, Mary J¹⁰, Perini, Rodolfo F¹⁰, Keefe, Stephen M¹⁰, Bajorin, Dean¹¹, Bellmunt, Joaquim¹², O'Donnell, Peter H³

المصدر: Lancet Oncology. Nov2017, Vol. 18 Issue 11, p1483-1492. 10p.

مصطلحات موضوعية: *PEMBROLIZUMAB, *CISPLATIN, *UROTHELIUM, *CANCER treatment, *CANCER chemotherapy, *CANCER, *THERAPEUTIC use of monoclonal antibodies, *CANCER invasiveness, *CLINICAL trials, *COMPARATIVE studies, *DRUG administration, *DRUG dosage, *DOSE-effect relationship in pharmacology, *DRUG toxicity, *INTERNATIONAL relations, *INTRAVENOUS therapy, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *MONOCLONAL antibodies, *PATIENT safety, *PROGNOSIS, *RESEARCH, *SURVIVAL analysis (Biometry), *TUMOR classification, *URINARY organs, *EVALUATION research, *RANDOMIZED controlled trials, *TREATMENT effectiveness, *BLIND experiment, *TRANSITIONAL cell carcinoma, *TUMORS

المؤلفون: Plimack, Elizabeth R¹ elizabeth.plimack@fccc.edu, Bellmunt, Joaquim², Gupta, Shilpa³, Berger, Raanan⁴, Chow, Laura Q M⁵, Juco, Jonathan⁶, Lunceford, Jared⁶, Saraf, Sanatan⁶, Perini, Rodolfo F⁶, O'Donnell, Peter H⁷, O'Donnell, Peter H⁷ (AUTHOR)

المصدر: Lancet Oncology. Feb2017, Vol. 18 Issue 2, p212-220. 9p.

مصطلحات موضوعية: *TRANSITIONAL cell carcinoma, *PEMBROLIZUMAB, *MEDICATION safety, *LIGANDS (Biochemistry), *CYTOLOGY, *RANDOMIZED controlled trials, *THERAPEUTICS, *ANTINEOPLASTIC agents, *THERAPEUTIC use of monoclonal antibodies, *CANCER relapse, *CLINICAL trials, *COMPARATIVE studies, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *METASTASIS, *PROGNOSIS, *RESEARCH, *SAFETY, *SURVIVAL, *TUMOR classification, *URINARY organs, *EVALUATION research, *TUMORS